Goldman Sachs’s iBio IBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-587
| Closed | -$78K | – | 5564 |
|
|
2022
Q2 | $78K | Buy |
587
+329
| +128% | +$43.7K | ﹤0.01% | 5186 |
|
|
2022
Q1 | $55K | Sell |
258
-473
| -65% | -$101K | ﹤0.01% | 5447 |
|
|
2021
Q4 | $201K | Buy |
731
+260
| +55% | +$71.5K | ﹤0.01% | 4997 |
|
|
2021
Q3 | $250K | Buy |
471
+293
| +165% | +$156K | ﹤0.01% | 4757 |
|
|
2021
Q2 | $134K | Buy |
178
+14
| +9% | +$10.5K | ﹤0.01% | 5046 |
|
|
2021
Q1 | $126K | Buy |
164
+110
| +204% | +$84.5K | ﹤0.01% | 4969 |
|
|
2020
Q4 | $29K | Buy |
54
+29
| +116% | +$15.6K | ﹤0.01% | 4599 |
|
|
2020
Q3 | $26K | Sell |
25
-115
| -82% | -$120K | ﹤0.01% | 4376 |
|
|
2020
Q2 | $156K | Sell |
140
-54
| -28% | -$60.2K | ﹤0.01% | 4068 |
|
|
2020
Q1 | $103K | Buy |
+194
| New | +$103K | ﹤0.01% | 4163 |
|
|
2016
Q2 | – | Sell |
-18
| Closed | -$50K | – | 4570 |
|
|
2016
Q1 | $50K | Buy |
+18
| New | +$50K | ﹤0.01% | 4219 |
|